From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

NCCN releases statement addressing ongoing chemotherapy shortages; shares survey results finding more than 90% of cancer centers are impacted

Last Updated: Tuesday, August 22, 2023

A survey by the Best Practices Committee of the National Comprehensive Cancer Network® (NCCN®) shows that 93% of 27 NCCN Member Institution cancer centers report a shortage of carboplatin and 70% report a similar lack of cisplatin, two treatments that are indicated hundreds of times throughout the NCCN Drugs & Biologics Compendium

National Comprehensive Cancer Network
Advertisement
News & Literature Highlights
Advertisement
Advertisement